TNF and glaucoma: Since there are no biomarkers available for the use in the clinical setting, it would be interesting to explore in future studies whether increased proinflammatory cytokine levels in blood, including TNF has a significant impact on glaucoma diagnosis, prognosis, and treatment monitoring, particularly in the early progression of the disease.